Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs17109512
rs17109512
0.800 GeneticVariation GWASDB We carried out a genome-wide association study of serum aspartate aminotransferase (AST) activity in 866 Amish participants of the Heredity and Phenotype Intervention Heart Study and identified significant association of AST activity with a cluster of single nucleotide polymorphisms located on chromosome 10q24.1 (peak association was rs17109512; P=2.80E-14), in the vicinity of GOT1, the gene encoding cytosolic AST (cAST). 21900944

2011

dbSNP: rs17109512
rs17109512
0.800 GeneticVariation GWASCAT We carried out a genome-wide association study of serum aspartate aminotransferase (AST) activity in 866 Amish participants of the Heredity and Phenotype Intervention Heart Study and identified significant association of AST activity with a cluster of single nucleotide polymorphisms located on chromosome 10q24.1 (peak association was rs17109512; P=2.80E-14), in the vicinity of GOT1, the gene encoding cytosolic AST (cAST). 21900944

2011

dbSNP: rs10272006
rs10272006
SP4
G 0.700 GeneticVariation GWASCAT GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network. 31311600

2019

dbSNP: rs11066280
rs11066280
0.700 GeneticVariation GWASCAT The Korea Biobank Array: Design and Identification of Coding Variants Associated with Blood Biochemical Traits. 30718733

2019

dbSNP: rs117983281
rs117983281
0.700 GeneticVariation GWASCAT Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers. 30589442

2019

dbSNP: rs118107800
rs118107800
0.700 GeneticVariation GWASCAT Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers. 30589442

2019

dbSNP: rs11820744
rs11820744
T 0.700 GeneticVariation GWASCAT GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network. 31311600

2019

dbSNP: rs12231737
rs12231737
T 0.700 GeneticVariation GWASCAT The Korea Biobank Array: Design and Identification of Coding Variants Associated with Blood Biochemical Traits. 30718733

2019

dbSNP: rs12580745
rs12580745
0.700 GeneticVariation GWASCAT Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers. 30589442

2019

dbSNP: rs12803802
rs12803802
0.700 GeneticVariation GWASCAT Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers. 30589442

2019

dbSNP: rs137866734
rs137866734
0.700 GeneticVariation GWASCAT Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers. 30589442

2019

dbSNP: rs138424361
rs138424361
0.700 GeneticVariation GWASCAT Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers. 30589442

2019

dbSNP: rs139271658
rs139271658
G 0.700 GeneticVariation GWASCAT GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network. 31311600

2019

dbSNP: rs147627531
rs147627531
0.700 GeneticVariation GWASCAT Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers. 30589442

2019

dbSNP: rs17342773
rs17342773
0.700 GeneticVariation GWASCAT Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers. 30589442

2019

dbSNP: rs17835714
rs17835714
0.700 GeneticVariation GWASCAT Genome-Wide Association Study Identifies Loci for Liver Enzyme Concentrations in Mexican Americans: The GUARDIAN Consortium. 31219225

2019

dbSNP: rs191610380
rs191610380
0.700 GeneticVariation GWASCAT Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers. 30589442

2019

dbSNP: rs2371605
rs2371605
0.700 GeneticVariation GWASCAT Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers. 30589442

2019

dbSNP: rs319991
rs319991
0.700 GeneticVariation GWASCAT Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers. 30589442

2019

dbSNP: rs34173
rs34173
0.700 GeneticVariation GWASCAT Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers. 30589442

2019

dbSNP: rs3747207
rs3747207
0.700 GeneticVariation GWASCAT Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers. 30589442

2019

dbSNP: rs4823173
rs4823173
0.700 GeneticVariation GWASCAT In the PNPLA3 gene, rs4823173 (P = 3.44 × 10<sup>-10</sup> ), rs2896019 (P = 7.29 × 10<sup>-9</sup> ), and rs2281135 (P = 8.73 × 10<sup>-9</sup> ) were significantly associated with AST levels. 31219225

2019

dbSNP: rs62141163
rs62141163
A 0.700 GeneticVariation GWASCAT GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network. 31311600

2019

dbSNP: rs671
rs671
A 0.700 GeneticVariation GWASCAT Moreover, 9 missense variants were newly identified, of which we identified new associations between a common population-specific missense variant, rs671 (p.Glu457Lys) of ALDH2, and two traits including aspartate aminotransferase (P = 5.20 × 10<sup>-13</sup>) and alanine aminotransferase (P = 4.98 × 10<sup>-8</sup>). 30718733

2019

dbSNP: rs686288
rs686288
0.700 GeneticVariation GWASCAT Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers. 30589442

2019